Literature DB >> 14054451

HAEMORRHAGIC CYSTITIS AND CYCLOPHOSPHAMIDE.

P GEORGE.   

Abstract

Entities:  

Keywords:  BLOOD TRANSFUSION; CHILD; CYCLOPHOSPHAMIDE; CYSTITIS; HEMATURIA; NEUROBLASTOMA; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1963        PMID： 14054451     DOI： 10.1016/s0140-6736(63)90653-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.

Authors:  Chen Lossos; Yunpeng Liu; Kellie E Kolb; Amanda L Christie; Alexandria Van Scoyk; Sanjay M Prakadan; Kay Shigemori; Kristen E Stevenson; Sara Morrow; Olivia D Plana; Cameron Fraser; Kristen L Jones; Huiyun Liu; Christian P Pallasch; Rebecca Modiste; Quang-De Nguyen; Jeffrey W Craig; Elizabeth A Morgan; Francisco Vega; Jon C Aster; Kristopher A Sarosiek; Alex K Shalek; Michael T Hemann; David M Weinstock
Journal:  Cancer Discov       Date:  2019-04-30       Impact factor: 39.397

2.  CYCLOPHOSPHAMIDE INDUCED HAEMORRHAGIC CYSTITIS (A Case Report).

Authors:  P P Varma; D B Subba; P Madhoosudanan
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Role of ERK signaling in bladder urothelium in response to cyclophosphamide injury.

Authors:  Sridhar Tatarao Narla; Joanne Lindsey Duara; Daniel Scott Bushnell; Mehdi Nouraie; Jacqueline Holden; Katherine Pfister; Peter C Lucas; Sunder Sims-Lucas; Carlton Matthew Bates
Journal:  Physiol Rep       Date:  2022-07

4.  AKT Signaling Downstream of KGF Is Necessary and Sufficient for Blocking Cyclophosphamide Bladder Injury.

Authors:  Sridhar T Narla; Daniel S Bushnell; Joanne L Duara; Carlton M Bates
Journal:  Am J Pathol       Date:  2022-01-19       Impact factor: 5.770

5.  Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.

Authors:  J M Hows; A Mehta; L Ward; K Woods; R Perez; M Y Gordon; E C Gordon-Smith
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.